Theragnostics, GE Healthcare announce prostate cancer diagnostic partnership

9th October 2019 Uncategorised 0

Theragnostics will lead the development of the tracer, GalliProst, while GE Healthcare will lead all pre-approval commercial preparations.

More: Theragnostics, GE Healthcare announce prostate cancer diagnostic partnership
Source: News